299 related articles for article (PubMed ID: 19211093)
21. Effect of posterior sub-tenon administration of triamcinolone acetonide on leukocyte dynamics in rat retinal microcirculation after panretinal photocoagulation.
Mizuno D; Matsubara A; Ogura Y
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2127-33. PubMed ID: 18436845
[TBL] [Abstract][Full Text] [Related]
22. VEGF-A induced hyperpermeability of blood-retinal barrier endothelium in vivo is predominantly associated with pinocytotic vesicular transport and not with formation of fenestrations. Vascular endothelial growth factor-A.
Hofman P; Blaauwgeers HG; Tolentino MJ; Adamis AP; Nunes Cardozo BJ; Vrensen GF; Schlingemann RO
Curr Eye Res; 2000 Aug; 21(2):637-45. PubMed ID: 11148600
[TBL] [Abstract][Full Text] [Related]
23. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in macular edema with central retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Eguchi S; Shimada K; Hori S
Curr Eye Res; 2011 Mar; 36(3):256-63. PubMed ID: 21275514
[TBL] [Abstract][Full Text] [Related]
24. Changes of aqueous vascular endothelial growth factor and interleukin-6 after intravitreal triamcinolone for branch retinal vein occlusion.
Park SP; Ahn JK
Clin Exp Ophthalmol; 2008 Dec; 36(9):831-5. PubMed ID: 19278477
[TBL] [Abstract][Full Text] [Related]
25. Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs.
Tameesh MK; Lakhanpal RR; Fujii GY; Javaheri M; Shelley TH; D'Anna S; Barnes AC; Margalit E; Farah M; De Juan E; Humayun MS
Am J Ophthalmol; 2004 Nov; 138(5):829-39. PubMed ID: 15531319
[TBL] [Abstract][Full Text] [Related]
26. Macular star secondary to nasal branch retinal vein occlusion.
Parodi MB; Iacono P; Ravalico G
Ophthalmic Surg Lasers Imaging; 2009; 40(5):504-5. PubMed ID: 19772278
[TBL] [Abstract][Full Text] [Related]
27. Changes of inflammatory factors after intravitreal triamcinolone acetonide for macular edema with central retinal vein occlusion.
Noma H; Funatsu H; Mimura T
J Ocul Pharmacol Ther; 2013 Apr; 29(3):363-5. PubMed ID: 23046435
[TBL] [Abstract][Full Text] [Related]
28. Periocular triamcinolone acetonide as treatment for macular edema secondary to branch vein occlusion associated with retinal arteriovenous malformation.
Federici T; Batlle I
Retina; 2006; 26(9):1079-80. PubMed ID: 17151499
[No Abstract] [Full Text] [Related]
29. Branch retinal vein occlusion: clinical findings, natural history, and management.
Margolis R; Singh RP; Kaiser PK
Compr Ophthalmol Update; 2006; 7(6):265-76. PubMed ID: 17244442
[TBL] [Abstract][Full Text] [Related]
30. Inner Retinal Changes in Acute Experimental BRVO Treated With Bevacizumab or Triamcinolone Acetonide.
McAllister IL; Vijayasekaran S; Bhikoo R; Chen FK; Zhang D; Kanagalingam E; McLenachan S; Yu DY
Transl Vis Sci Technol; 2023 Feb; 12(2):11. PubMed ID: 36753186
[TBL] [Abstract][Full Text] [Related]
31. Electrophysiological consequences of experimental branch retinal vein occlusion in pigs and the effect of dorzolamide.
Ejstrup R; Scherfig E; la Cour M
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):952-8. PubMed ID: 21051705
[TBL] [Abstract][Full Text] [Related]
32. Pigment epithelium-derived factor and vascular endothelial growth factor in branch retinal vein occlusion with macular edema.
Noma H; Funatsu H; Mimura T; Harino S; Eguchi S; Hori S
Graefes Arch Clin Exp Ophthalmol; 2010 Nov; 248(11):1559-65. PubMed ID: 20714746
[TBL] [Abstract][Full Text] [Related]
33. Neuronal degeneration and associated alterations in cytokine and protein in an experimental branch retinal venous occlusion model.
McAllister IL; Vijayasekaran S; Zhang D; McLenachan S; Chen FK; Yu DY
Exp Eye Res; 2018 Sep; 174():133-146. PubMed ID: 29803555
[TBL] [Abstract][Full Text] [Related]
34. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
Yang LP; Sun HL; Wu LM; Guo XJ; Dou HL; Tso MO; Zhao L; Li SM
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
[TBL] [Abstract][Full Text] [Related]
35. 25-gauge vitrectomy and triamcinolone acetonide-assisted internal limiting membrane peeling for chronic cystoid macular edema associated with branch retinal vein occlusion.
Ma J; Yao K; Zhang Z; Tang X
Retina; 2008; 28(7):947-56. PubMed ID: 18698296
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of intraocular neovascularization caused by retinal ischemia in pigs by PKCbeta inhibition with LY333531.
Danis RP; Bingaman DP; Jirousek M; Yang Y
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):171-9. PubMed ID: 9430559
[TBL] [Abstract][Full Text] [Related]
37. Natural history and histology in a rat model of laser-induced photothrombotic retinal vein occlusion.
Zhang Y; Fortune B; Atchaneeyasakul LO; McFarland T; Mose K; Wallace P; Main J; Wilson D; Appukuttan B; Stout JT
Curr Eye Res; 2008 Apr; 33(4):365-76. PubMed ID: 18398711
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of triamcinolone acetonide following intravitreal injection in New Zealand white rabbits.
McGee DH; Dembinska O; Gruebbel MM
Int J Toxicol; 2005; 24(6):419-25. PubMed ID: 16393934
[TBL] [Abstract][Full Text] [Related]
39. Vascular endothelial growth factor receptor-2 in macular oedema with retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Eguchi S
Ophthalmic Res; 2012; 48(1):56-8. PubMed ID: 22415022
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoids exert differential effects on the endothelium in an in vitro model of the blood-retinal barrier.
van der Wijk AE; Canning P; van Heijningen RP; Vogels IMC; van Noorden CJF; Klaassen I; Schlingemann RO
Acta Ophthalmol; 2019 Mar; 97(2):214-224. PubMed ID: 30168271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
